Search results for: Adrian Towse
Filter search results
OHE at ISPOR 2019
8 May 2019
…the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2019 conference in New Orleans, 18-22 May. Graham Cookson, Lotte Steuten, and Adrian Towse will all be attending the conference and…
OHE at the 2019 Health Technology Assessment International (HTAi) Annual Meeting
7 June 2019
…Beyond 2020: Ready For The New Decade? Adrian Towse, Lotte Steuten, Margherita Neri, and Mikel Berdud will be attending to present work from some of OHE’s projects. Public health interventions…
ISPOR Issue Panel Roundup: Are Our HTA Methods Fit for Purpose for Gene Therapies?
6 June 2022
…the potential opportunities associated with gene therapies to be realised. Director Emeritus of OHE, Adrian Towse, moderated the session, in which three different perspectives were presented: academic health economist, patient…
Biosimilars: Modelling the Evolution of the Market
16 June 2010
…of Prof Adrian Towse and Dr Jorge Mestre-Ferrandiz. Describing and/or forecasting the market for biosimilars must first recognize that these products are not identical, i.e., not ‘biogenerics.’ This affects both…
Recently Published: Payer Perspectives on Future Acceptability of Comparative Effectiveness and Relative Effectiveness Research
18 August 2015
…Journal of Comparative Effectiveness Research (Epub ahead of print). Download the full paper here. For more information on OHE’s research in this area, please contact Adrian Towse or Jorge Mestre-Ferrandiz….
Opportunity Costs of New Health Care Technologies: A Research Agenda
8 August 2018
…(German Cancer Research Center, DKFZ), Bernarda Zamora and Adrian Towse set out a research agenda. The authors propose new approaches in three areas to improve understanding of supply-side opportunity costs…
New Publication: Advanced Therapy Medicinal Products and Health Technology Assessment
12 October 2018
…OHE’s Grace Hampson and Adrian Towse, alongside Bengt Jönsson (Stockholm School of Economics), Jonathan Michaels (University of Sheffield), J.-Matthias von der Schulenburg (Leibniz University, Hannover), and Olivier Wong (Medi-Qualite Omega),…
How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine? Where are we 6 Months on?
1 July 2021
…Disease (COVID-19) Vaccine?” co-authored by OHE’s Adrian Towse and Isobel Firth , along with Kalipso Chalkidou , Imperial College, Hannah Kettler , (PATH), and Rachel Silverman , Center for Global…
Spotlight on OHE: EQ-5D-5L, Next Generation Sequencing, and MCDA
19 December 2014
…An HTA perspective on the implications for drug reimbursement Speaking in Amsterdam on 13th November 2014 Adrian Towse delivered a presentation at the 3rd Annual Health Economics & Personalised…